Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-13-397786
Filing Date
2013-10-11
Accepted
2013-10-11 15:48:15
Documents
5
Effectiveness Date
2013-10-11

Document Format Files

Seq Description Document Type Size
1 S-8 d611114ds8.htm S-8 64622
2 EX-5.1 d611114dex51.htm EX-5.1 5249
3 EX-23.2 d611114dex232.htm EX-23.2 1515
4 EX-23.3 d611114dex233.htm EX-23.3 2817
5 GRAPHIC g611114g44b12.jpg GRAPHIC 3356
  Complete submission text file 0001193125-13-397786.txt   80055
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-191695 | Film No.: 131148009
SIC: 2834 Pharmaceutical Preparations